Former Chief Financial Officer · Niagen Bioscience, Inc. (NAGE)

Brianna Gerber

A named executive officer of Niagen Bioscience in every fiscal year CompBrief holds from FY2022 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$450,969

Salary $215,000Stock awards $0

FY2022: $842,384

3rd of 5 named executive officers at Niagen Bioscience by FY2024 total.

5 named officers on file for Niagen Bioscience, FY2024

Brianna Gerber’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 4 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Niagen Bioscience’s whole pay program stands against its peers

  • Niagen Bioscience’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NAGE→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2025 (DEF 14A).

Free

Get Brianna Gerber’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Brianna Gerber compensation by year

Niagen Bioscience Summary Compensation Table · all 2 fiscal years held
In US dollars, as Niagen Bioscience reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2024
Salary$269,096$215,000
Bonus$150,000$0
Stock awards$113,751$0
Option awards$218,818$227,445
Non-equity incentive$83,869$0
Pension and deferred compensation$0$0
All other$6,851$8,524
Total$842,384$450,969

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Niagen Bioscience, Inc. DEF 14A filed April 29, 2025, accession 0001628280-25-020690, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Niagen Bioscience, Inc. filed document, accession 0001628280-25-020690. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2025.

$842K
$451K
FY22
FY24
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
RSU67,308$113,077—
Option3,333—$3.27
Option13,333—$11.83
Option56,576—$2.67
Option2,222—$4.92
Option100,460—$1.69

Per the Outstanding Equity Awards at Fiscal Year-End table in Niagen Bioscience, Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Niagen Bioscience’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Robert FriedChief Executive Officer$1,212,131
Ozan PamirChief Financial Officer$461,641
Brianna Gerber · this pageFormer Chief Financial Officer$450,969
James LeeController, Former Interim Chief Financial Officer$374,470
Carlos LopezSenior Vice President, General Counsel$347,637

The full Niagen Bioscience compensation record

free company brief

This page is one person within Niagen Bioscience's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Niagen Bioscience's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Brianna Gerber's compensation dossier · One-time report. No refunds.